Low Dose Spironolactone Monotherapy in the Management of Stage I Essential Hypertension: A Pilot Randomized, Double-Blind, Placebo-Controlled Trial

Background: High blood pressure (BP) is a common chronic disease needs long life drug consumption to control. Spironolactone could be used as the fourth-line therapy in patients with resistant hypertension. However, there is no study to determine the effects of low dose spironolactone as a first lin...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Acta Cardiologica Sinica 2018-01, Vol.34 (1), p.59-65
Hauptverfasser:	Attar, Armin, Sadeghi, Amir-Abbas, Amirmoezi, Fatemeh, Aghasadeghi, Kamran
Format:	Artikel
Sprache:	eng
Schlagworte:	Aldosterone antagonist Hypertension MEDLINE Monotherapy Original SCI Scopus Spironolactone
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!